Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2017

Jun 27, 2017

30071_dirs_2017-06-27_0dc34ff7-766c-4a3e-817f-e4db14fb84bf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-06-22

Reporting Person: SULPIZIO RICHARD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-06-22 ResMed Common Stock S 65887 $77.819 Disposed 0 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 4429 Direct

Footnotes

F1: Sale executed by Bank of America, N.A., Trustee of the Magali Charitable Remainder Unitrust. Mr. Sulpizio has no control over the timing of any disposition of the shares gifted.

F2: Bank of America, N.A. is Trustee of the Magali Charitable Remainder Unitrust and Mr. Sulpizio has no control over the disposition of the equities held.